blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2397851

EP2397851 - Method for selecting mevalonate synthesis modulators using cells derived from pluripotent human cells [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.11.2015
Database last updated on 24.04.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Centre d'Etude des Cellules Souches
5, rue Henri Desbruères
91000 Evry / FR
[2011/51]
Inventor(s)01 / Pinset, Christian
111 boulevard Magenta
75010, Paris / FR
 [2011/51]
Representative(s)Hirsch & Associés
154 Boulevard Haussmann
75008 Paris / FR
[N/P]
Former [2011/51]Hirsch & Associés
58, avenue Marceau
75008 Paris / FR
Application number, filing date10166631.121.06.2010
[2011/51]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP2397851
Date:21.12.2011
Language:FR
[2011/51]
Type: B1 Patent specification 
No.:EP2397851
Date:07.01.2015
Language:FR
[2015/02]
Search report(s)(Supplementary) European search report - dispatched on:EP12.07.2011
ClassificationIPC:G01N33/50, C12N5/077, C12N5/0735
[2011/51]
CPC:
G01N33/5073 (EP,US); G01N33/5014 (US); C12N5/0662 (EP,US);
C12Q1/025 (US); C12N2500/38 (EP,US); C12N2501/115 (EP,US);
C12N2506/02 (EP,US); C12N2506/45 (EP,US); G01N2500/04 (US);
G01N2500/10 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/51]
TitleGerman:Auswahlmethode der Mevalonat-Synthesemodulatoren unter Einsatz von Derivatzellen pluripotenter menschlicher Zellen[2011/51]
English:Method for selecting mevalonate synthesis modulators using cells derived from pluripotent human cells[2011/51]
French:Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines[2011/51]
Examination procedure19.06.2012Amendment by applicant (claims and/or description)
21.06.2012Examination requested  [2012/31]
19.07.2012Despatch of a communication from the examining division (Time limit: M04)
14.11.2012Reply to a communication from the examining division
27.11.2013Despatch of a communication from the examining division (Time limit: M06)
03.06.2014Reply to a communication from the examining division
06.08.2014Communication of intention to grant the patent
28.11.2014Fee for grant paid
28.11.2014Fee for publishing/printing paid
28.11.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.07.2012
Opposition(s)08.10.2015No opposition filed within time limit [2015/51]
Fees paidRenewal fee
02.07.2012Renewal fee patent year 03
01.07.2013Renewal fee patent year 04
30.06.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.06.2010
AL07.01.2015
AT07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MK07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
PT07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
[2018/46]
Former [2018/34]HU21.06.2010
AT07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MK07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
PT07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
Former [2018/30]HU21.06.2010
AT07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MK07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
Former [2017/38]HU21.06.2010
AT07.01.2015
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
SM07.01.2015
TR07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
Former [2017/03]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
MT07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
Former [2016/20]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
IE21.06.2015
LU21.06.2015
Former [2016/11]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
LU21.06.2015
Former [2016/09]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
MC07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2016/03]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
IT07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/49]AT07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/39]AT07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
LV07.01.2015
NL07.01.2015
PL07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/38]AT07.01.2015
ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
PL07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
IS07.05.2015
Former [2015/37]ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
PL07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
GR08.04.2015
Former [2015/36]ES07.01.2015
FI07.01.2015
HR07.01.2015
LT07.01.2015
SE07.01.2015
BG07.04.2015
NO07.04.2015
Former [2015/35]ES07.01.2015
LT07.01.2015
NO07.04.2015
Former [2015/33]ES07.01.2015
Documents cited:Search[I]WO2005111197  (WISCONSIN ALUMNI RES FOUND [US], et al) [I] 8-12 * column 64 - column 68 *;
 [X]WO2008094597  (UNIV GEORGIA RES FOUND [US], et al) [X] 1,3-5 * page 33 - page 34; example 8; claims 12, 24 *;
 [I]WO2008150498  (UNIV GEORGIA [US], et al) [I] 1-7 * figure 3b *;
 [I]US2009081784  (VODYANYK MAKSYM A [US], et al) [I] 1-7 * the whole document *;
 [I]  - KARLSSON C ET AL, "Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine", STEM CELL RESEARCH,, vol. 3, no. 1, doi:10.1016/J.SCR.2009.05.002, ISSN 1873-5061, (20090701), pages 39 - 50, (20090519), XP026285470 [I] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.scr.2009.05.002
 [I]  - BOYD NOLAN L ET AL, "Human Embryonic Stem Cell-Derived Mesoderm-like Epithelium Transitions to Mesenchymal Progenitor Cells", TISSUE ENGINEERING PART A, (200908), vol. 15, no. 8, ISSN 1937-3341, pages 1897 - 1907, XP002609977 [I] 1-7 * page 1898; figures 3, 4 *

DOI:   http://dx.doi.org/10.1089/TEN.TEA.2008.0351
 [I]  - KITAGAWA MICHINORI ET AL, "Differentiation of mesodermal cells from pluripotent stem cells", INTERNATIONAL JOURNAL OF HEMATOLOGY, (201004), vol. 91, no. 3, ISSN 0925-5710, pages 373 - 383, XP002609978 [I] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1007/S12185-010-0518-8
 [T]  - DE PEPPO GIUSEPPE MARIA ET AL, "Human Embryonic Mesodermal Progenitors Highly Resemble Human Mesenchymal Stem Cells and Display High Potential for Tissue Engineering Applications", TISSUE ENGINEERING PART A, (201007), vol. 16, no. 7, ISSN 1937-3341, pages 2161 - 2182, XP002609979 [T] * the whole document *

DOI:   http://dx.doi.org/10.1089/TEN-TEA.2009.0629
ExaminationWO2009100760
    - EUN J GANG ET AL, "SSEA-4 identifies mesenchymal stem cells from bone marrow", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 109, no. 4, doi:10.1182/BLOOD-2005-11-010504, ISSN 0006-4971, (20070215), pages 1743 - 1751, (20061024), XP008152783

DOI:   http://dx.doi.org/10.1182/blood-2005-11-010504
by applicantWO2004055174
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.